AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Recruitment For Clinical Study Of Screening Test Begins.(NMP66 blood test for breast cancer detection)
2001 JUN 14 - (NewsRx Network) -- Matritech, Inc. (NMPS) announced that it has begun patient recruitment for a multicenter clinical study of its NMP66 blood test for the early detection of breast cancer.
The clinical study, which will be conducted at six medical centers around the U.S., will enroll approximately 1,000 patients. It will include about 700 women with lesions that are either visible on mammogram or palpable, and who have been recommended by their physicians to have a further diagnostic procedure such as biopsy. An additional 300 women with normal mammograms will also be recruited.
The trial will investigate the ability of the NMP66 blood test to detect cancer, differentiate between benign and malignant lesions, and identify patients with normal mammograms. The goal of the study is to investigate the NMP66 blood test as a potential screening procedure for breast cancer.
"The key to fighting and treating breast cancer is early detection," said David L. Corbet, Matritech. "According to the American Cancer Society, five-year survival for women in whom the disease is detected at its earliest stage is greater than 96%. However, survival for this length of time decreases to 21% in women with late-stage, metastatic disease."
"Despite the encouraging progress that the medical community has made in detecting breast cancer, only 62% of breast cancers diagnosed between 1989 and 1995 were found while still localized," added Corbet. "While mammography is still the best detection method, the number of false positives is high. Clearly, there is a need for a blood-based screening tool to enhance existing methods of detecting breast cancer, and NMP66 has the potential to fulfill this role."
"This is the type of test my patients have been hoping to use for over 20 years," said Avi BenOra, MD, a radiologist and former president of the Arizona division of the American Cancer Society. "Because almost half the women in the U.S. who should be getting annual mammograms are not, there is a critical need ...
- Biomarker Tech launches study for breast cancer blood test.
- Magazine article from: Diagnostic Update April 6, 2006 700+ words
...launches study for breast cancer blood test By KAREN YOUNG...study for its blood test that it says detects breast cancer, which if approved...tool in detecting breast cancer without the discomfort...studies of the blood test have shown ...
- Power3 Medical Files Two CIP Patent Applications for BC-SeraPro Breast Cancer...
- Press release article from: Business Wire November 19, 2008 700+ words
...and Detection of Early Breast Cancer (DCIS) HOUSTON...BC-SeraPro[TM] Breast Cancer blood test and biomarkers by Dr...extra finding that the blood test can distinguish between invasive breast cancer and the earlier, harder...
- Mercy joins international research trial for breast cancer blood test.(ONA News)
- Magazine article from: Oklahoma Nurse September 1, 2006 700+ words
...determine if a simple blood test is viable as a...screening tool for breast cancer detection. Mercy...with a low-cost blood test that will make...be screened for breast cancer," said Dr. Hollingsworth...at High Risk for Breast Cancer" where he ...
- Study Shows Combination Therapy Promising for HER-2-Positive Metastatic Breast...
- News wire article from: Ascribe Higher Education News Service April 1, 2002 700+ words
...with metastatic breast cancer that overexpresses...found that a new blood test may someday be a...with metastatic breast cancer. This blood test has been found to...with metastatic breast cancer. However, the...
- Breast Cancer Blood Test Introduced to the Middle East.
- Press release article from: Business Wire February 18, 2008 700+ words
...MRI to diagnosis women with breast cancer, these procedures are available...diagnostic tool for the detection of breast cancer called BC-SeraPro[TM]. A simple, minimally invasive blood test for breast cancer, the test analyzes biomarkers...
- Women recruited for breast cancer blood test.(News)
- Newspaper article from: The Boston Herald Lasalandra, Michael May 24, 2001 700+ words
...to evaluate its blood test for early detection of breast cancer. The study by Matritech...company hopes the blood test will enhance or...existing methods of breast cancer detection. Mammograms...tissue. An accurate blood test could also reduce...
- Matritech Reports 'Proof of Clinical Concept' For Breast Cancer Blood Test Is...
- Press release article from: PR Newswire June 1, 2000 700+ words
...its proprietary NMP66 blood test for women with, or at risk of, breast cancer. The NMP66 test is...complete. "When breast cancer is discovered at its...development of this breast cancer blood test is therefore a high...
- Data from Matritech's NMP66 Breast Cancer Blood Test Presented at 28th Meeting...
- Press release article from: PR Newswire September 11, 2000 700+ words
...the company's NMP66 blood test for the detection of breast cancer has been formally presented...the NMP66 test. "When breast cancer is discovered at its earliest...and development of this breast cancer blood test is therefore of the highest...
Source: HighBeam Research, Recruitment For Clinical Study Of Screening Test Begins.(NMP66 blood...